ACPE Outcomes Disclosure Information
The School of Pharmacy has released a letter that addresses our accreditation status, its impact on our current Pharm.D. students as well as future applicants, and our course of action. The Dean of the School of Pharmacy, Dr. Anand Iyer, is dedicated to providing updated information to both our students and to our scholarly community. In the provided link, a copy of the letter can be viewed. The School of Pharmacy is in the process of appealing, and we remain steadfast in our commitment to our students’ educational and professional successes.
ACPE Outcomes Disclosures Information
ACPE mandates that Hampton University School of Pharmacy utilize the following language with regards to its current accreditation status:
“Hampton University School of Pharmacy’s Doctor of Pharmacy Program has been given the status of Accredited with Probation while under appeal by the Accreditation Council for Pharmacy Education, 190 South LaSalle Street, Suite 2850, Chicago, IL 60603, 312/664-3575; FAX 866/228-2631, web site www.acpe-accredit.org [acpe-accredit.org],” for compliance issues with Standard No. 17: Progression. For an explanation of the program’s Accredited with Probation while under appeal status, consult the Office of the Dean or ACPE.”
Response to Accreditation Status
- 80.9% of the 2019 graduating class completed the Pharm.D. program within four (4) years.
- The NAPLEX pass rate for the Class of 2019 was 65%.
- As of June 2020, 72.9% of the 2019 graduating class reported being employed within the profession of pharmacy, including 69.5% in community pharmacy practice and 3.4% in hospital pharmacy practice.
- 10.2% of the Pharm.D. graduates were accepted into a residency program or fellowship.